💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Immunomedics, Inc. (IMMU)
« Back to company indexIMMU Chatter Timeline
Stock Ticker for IMMU
Most Active Tweeters for IMMU
| User | Tweets |
|---|---|
| @biotechradar_eu | 1 |
| @Redeye_ | 1 |
| @ResearchPool | 1 |
Recent Tweets for IMMU
 |
@ResearchPool $IMMU #Immunicum AB Immunicum - Positive interim data for DCP-001: Immunicum has reported positive interim data fro… https://t.co/y1RNUzkxqK May 17th 2022, 10:05pm |
 |
@Redeye_ Redeye comments on Immunicum communicating interim data from its ADVANCE II trial: $IMMU https://t.co/TtKbU7I9A1 https://t.co/1P5DmPdsCj May 17th 2022, 7:05am |
 |
@biotechradar_eu Immunicum $IMMU Announces Positive Interim Results from ADVANCE II Study in AML Maintenance Treatment https://t.co/JXLYJPVJys May 16th 2022, 6:05am |
|
@ResearchPool $IMMU #Immunicum AB Immunicum - Catalysts approaching for DCP-001: Immunicum specialises in the research and develo… https://t.co/RBSC0m9LG9 May 11th 2022, 10:05pm |
 |
@AnalyserNU Analys - Immunicum Catalysts approaching for DCP-001 https://t.co/bn7zdLxxb3 $IMMU #aktieanalys May 11th 2022, 10:05am |
|
@Redeye_ Immunicum's Q1'22 report came in without any major surprises. Our analyst gives a comment: $IMMU… https://t.co/p4zIxhfDmt May 10th 2022, 11:05am |
|
@biotechradar_eu Immunicum $IMMU Interim Report January – March 2022 https://t.co/PNTgQuNxYA May 10th 2022, 8:05am |
|
@biotechradar_eu Immunicum $IMMU Appoints Leopold Bertea as Chief Technology Officer https://t.co/spmwTkb7pI May 5th 2022, 6:05am |
|
@biotechradar_eu Immunicum $IMMU to Present Preclinical Data Demonstrating Synergy of DCP-001 with Standard Treatments for Acute Mye… https://t.co/pfdFQiToqU May 3rd 2022, 2:05pm |
 |
@andrewross11 $gild long 900 @ 59.65; now that $immu impairment has been put to sleep; earnings going forward should be stellar;… https://t.co/z47zYu3FNj April 29th 2022, 7:04pm |
 |
@newsfilterio Gilead first quarter sales, earnings beat Street estimates $IMMU https://t.co/SmhjI0USLA April 29th 2022, 12:04am |
|
@newsfilterio Gilead earnings beat Street estimates, writedown taken on cancer drug $IMMU https://t.co/dqu5ZObgOD April 29th 2022, 12:04am |
 |
@BiotechObserver @bradloncar Hey, at least they got some accounting benefits from $IMMU acquisition lol April 28th 2022, 10:04pm |
|
@biotechradar_eu Immunicum $IMMU Immunicum Publishes Phase II MERECA Trial Results of Ilixadencel in Kidney Cancer in European Urolo… https://t.co/1NPETU6aky April 28th 2022, 7:04am |
 |
@Hall8Jack RT @BertrandBio: US biotech news flow this morning: $TGTX BLA withdrawal from this weekend, a settlement of class action from former $IMMU,… April 18th 2022, 4:04pm |
 |
@bradloncar @ZacharyBrennan Back then $IMMU felt like one of those shady biotech companies that wasn't serious. Definitely an i… https://t.co/qKi2XvOtho April 18th 2022, 12:04pm |
 |
@gcasher @equitydotguru 20 years; ended in a buyout; $IMMU April 14th 2022, 12:04pm |
 |
@PaulTorresCohen Paul Torres-Cohen $IMMU April 13th 2022, 4:04am |
 |
@kingkappital $IMMU was at 9 .. 6 months before the buyout. "double downgraded" day before the life changing data released,… https://t.co/Q559Cn5CEu April 10th 2022, 9:04pm |
 |
@GripRoom The manipulation on $RAD today is pretty nuts. Might turn into one of those $IMMU type downgrades. April 7th 2022, 7:04pm |
 |
@stevedoc22 @Sports_bios $GILD is taking a write down of $IMMU deal, they are reportedly firing > 100 employees and their "top… https://t.co/c479vPfGPI March 10th 2022, 12:03pm |
 |
@DuaneReadeSanta What would $IMMU's market cap be as a public company today? March 7th 2022, 3:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.